<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Intestinal <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> in a 38-year-old woman was diagnosed because of the history of recurrent oral aphthous <z:mpath ids='MPATH_579'>ulcers</z:mpath>, <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum-like eruptions, genital <z:mpath ids='MPATH_579'>ulcer</z:mpath>, and endoscopic findings of esophageal and ileocolonic punched-out <z:mpath ids='MPATH_579'>ulcers</z:mpath> with colonic longitudinal <z:mpath ids='MPATH_579'>ulcers</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Esophageal lesions and colonic longitudinal <z:mpath ids='MPATH_579'>ulcers</z:mpath> are rarely seen in intestinal <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:mpath ids='MPATH_579'>ulcers</z:mpath> of esophagus and ileocolon healed with 3 wk of treatment with <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and <z:chebi fb="0" ids="6775">mesalazine</z:chebi> without any adverse effect </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="6775">Mesalazine</z:chebi> may decrease the total dose of <z:chebi fb="2" ids="8378">prednisolone</z:chebi> required to treat the disease </plain></SENT>
</text></document>